Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers

Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)

(2014) J. Goldstein et al.   ANNALS OF ONCOLOGY

Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial

(2014) D. Klingbiel et al.   ANNALS OF ONCOLOGY

KRAS Mutation is Associated with Worse Prognosis in Stage III or High-risk Stage II Colon Cancer Patients Treated with Adjuvant FOLFOX

(2014) Dae-Won Lee et al.   ANNALS OF SURGICAL ONCOLOGY

Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies

(2014) S. Venderbosch et al.   CLINICAL CANCER RESEARCH

The prognostic role of microsatellite instability, codon-specificKRAS, andBRAFmutations in colon cancer

(2014) Chun-Chi Lin et al.   JOURNAL OF SURGICAL ONCOLOGY

A Further Investigation of Combined Mismatch Repair and BRAFV600E Mutation Specific Immunohistochemistry as a Predictor of Overall Survival in Colorectal Carcinoma

(2014) Nathan Luey et al.   PLoS One

The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer

(2013) V Eklöf et al.   BRITISH JOURNAL OF CANCER

Body Mass Index and Microsatellite Instability in Colorectal Cancer: A Population-based Study

(2013) M. Hoffmeister et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

(2013) Frank A. Sinicrope et al.   JOURNAL OF CLINICAL ONCOLOGY

Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication

(2013) Paul Lochhead et al.   JNCI-Journal of the National Cancer Institute

Rare Though Not Mutually Exclusive: A Report of Three Cases of Concomitant KRAS and BRAF Mutation and a Review of the Literature

(2013) Ibrahim Halil Sahin et al.   Journal of Cancer

Toward a Molecular Classification of Colorectal Cancer: The Role of BRAF

(2013) Alexandra Thiel et al.   Frontiers in Oncology

Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series

(2012) M. A. Merok et al.   ANNALS OF ONCOLOGY

BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics

(2012) A. I. Phipps et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value

(2012) P. G. Gavin et al.   CLINICAL CANCER RESEARCH

Molecular Pathways: Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive, and Therapeutic Implications

(2012) F. A. Sinicrope et al.   CLINICAL CANCER RESEARCH

BRAF Mutations in Colorectal Cancer Are Associated With Distinct Clinical Characteristics and Worse Prognosis

(2012) Matthew F. Kalady et al.   DISEASES OF THE COLON & RECTUM

Correlation of tumour BRAF mutations andMLH1methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification

(2012) Michael T Parsons et al.   JOURNAL OF MEDICAL GENETICS

KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics

(2012) Daniëlle A.M. Heideman et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

High Lymph Node Yield is Related to Microsatellite Instability in Colon Cancer

(2011) E. J. Th. Belt et al.   ANNALS OF SURGICAL ONCOLOGY

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

(2011) Ben Tran et al.   CANCER

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

(2011) S. Ogino et al.   CLINICAL CANCER RESEARCH

Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer

(2011) V. A. de Weger et al.   CLINICAL CANCER RESEARCH

Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer

(2011) Gordon Hutchins et al.   JOURNAL OF CLINICAL ONCOLOGY

The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients

(2010) A. Fariña-Sarasqueta et al.   ANNALS OF ONCOLOGY

Is BRAF Mutation Associated with Interval Colorectal Cancers?

(2010) Aasma Shaukat et al.   DIGESTIVE DISEASES AND SCIENCES

KRAS Mutation and Microsatellite Instability: Two Genetic Markers of Early Tumor Development That Influence the Prognosis of Colorectal Cancer

(2009) Garrett M. Nash et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial

(2009) Arnaud D. Roth et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer

(2008) A. J. French et al.   CLINICAL CANCER RESEARCH